BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

368 related articles for article (PubMed ID: 31140597)

  • 1. Upregulated microRNA-15b alleviates ovarian cancer through inhitbition of the PI3K/Akt pathway by targeting LPAR3.
    Li GC; Qin XL; Song HH; Li YN; Qiu YY; Cui SC; Wang YS; Wang H; Gong JL
    J Cell Physiol; 2019 Dec; 234(12):22331-22342. PubMed ID: 31140597
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting of SPP1 by microRNA-340 inhibits gastric cancer cell epithelial-mesenchymal transition through inhibition of the PI3K/AKT signaling pathway.
    Song SZ; Lin S; Liu JN; Zhang MB; Du YT; Zhang DD; Xu WH; Wang HB
    J Cell Physiol; 2019 Aug; 234(10):18587-18601. PubMed ID: 30953349
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA-99b suppresses human cervical cancer cell activity by inhibiting the PI3K/AKT/mTOR signaling pathway.
    Li YJ; Wang Y; Wang YY
    J Cell Physiol; 2019 Jun; 234(6):9577-9591. PubMed ID: 30480801
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpression of Long Noncoding RNA H19 Downregulates miR-140-5p and Activates PI3K/AKT Signaling Pathway to Promote Invasion, Migration and Epithelial-Mesenchymal Transition of Ovarian Cancer Cells.
    Xu H; Ding Y; Yang X
    Biomed Res Int; 2021; 2021():6619730. PubMed ID: 34250088
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of microRNA-135a on Cell Proliferation, Migration, Invasion, Apoptosis and Tumor Angiogenesis Through the IGF-1/PI3K/Akt Signaling Pathway in Non-Small Cell Lung Cancer.
    Zhou Y; Li S; Li J; Wang D; Li Q
    Cell Physiol Biochem; 2017; 42(4):1431-1446. PubMed ID: 28715819
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-301a Promotes Cell Proliferation and Resistance to Apoptosis through PTEN/PI3K/Akt Signaling Pathway in Human Ovarian Cancer.
    Ni J; Chen Y; Fei B; Zhu Y; Du Y; Liu L; Guo L; Zhu W
    Gynecol Obstet Invest; 2021; 86(1-2):108-116. PubMed ID: 33596588
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-98-5p modulates cervical cancer progression via controlling PI3K/AKT pathway.
    Xiao R; Wang H; Yang B
    Bioengineered; 2021 Dec; 12(2):10596-10607. PubMed ID: 34895048
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-133b inhibits proliferation and invasion of ovarian cancer cells through Akt and Erk1/2 inactivation by targeting epidermal growth factor receptor.
    Liu X; Li G
    Int J Clin Exp Pathol; 2015; 8(9):10605-14. PubMed ID: 26617770
    [TBL] [Abstract][Full Text] [Related]  

  • 9. METTL3-mediated maturation of miR-126-5p promotes ovarian cancer progression via PTEN-mediated PI3K/Akt/mTOR pathway.
    Bi X; Lv X; Liu D; Guo H; Yao G; Wang L; Liang X; Yang Y
    Cancer Gene Ther; 2021 Apr; 28(3-4):335-349. PubMed ID: 32939058
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RNA-binding protein IGF2BP2 enhances circ_0000745 abundancy and promotes aggressiveness and stemness of ovarian cancer cells via the microRNA-3187-3p/ERBB4/PI3K/AKT axis.
    Wang S; Li Z; Zhu G; Hong L; Hu C; Wang K; Cui K; Hao C
    J Ovarian Res; 2021 Nov; 14(1):154. PubMed ID: 34774079
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Downregulation of lncRNA ZEB1-AS1 Represses Cell Proliferation, Migration, and Invasion Through Mediating PI3K/AKT/mTOR Signaling by miR-342-3p/CUL4B Axis in Prostate Cancer.
    Ma T; Chen H; Wang P; Yang N; Bao J
    Cancer Biother Radiopharm; 2020 Nov; 35(9):661-672. PubMed ID: 32275162
    [No Abstract]   [Full Text] [Related]  

  • 12. Long noncoding RNA-JPX predicts the poor prognosis of ovarian cancer patients and promotes tumor cell proliferation, invasion and migration by the PI3K/Akt/mTOR signaling pathway.
    Li J; Feng L; Tian C; Tang YL; Tang Y; Hu FQ
    Eur Rev Med Pharmacol Sci; 2018 Dec; 22(23):8135-8144. PubMed ID: 30556851
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Down-regulated microRNA-223 or elevated ZIC1 inhibits the development of pancreatic cancer via inhibiting PI3K/Akt/mTOR signaling pathway activation.
    Zhu J; Lv J; Chen J; Zhang X; Ji Y
    Cell Cycle; 2020 Nov; 19(21):2851-2865. PubMed ID: 33064959
    [No Abstract]   [Full Text] [Related]  

  • 14. HULC functions as an oncogene in ovarian carcinoma cells by negatively modulating miR-125a-3p.
    Chu P; Xu L; Su H
    J Physiol Biochem; 2019 Jun; 75(2):163-171. PubMed ID: 30863948
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-493-5p inhibits proliferation and metastasis of osteosarcoma cells by targeting Kruppel-like factor 5.
    Zhang Z; Luo G; Yu C; Yu G; Jiang R; Shi X
    J Cell Physiol; 2019 Aug; 234(8):13525-13533. PubMed ID: 30773645
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-134 inhibits tumor stem cell migration and invasion in oral squamous cell carcinomas via downregulation of PI3K-Akt signaling pathway by inhibiting LAMC2 expression.
    Zhou YM; Yao YL; Liu W; Shen XM; Shi LJ; Wu L
    Cancer Biomark; 2020; 29(1):51-67. PubMed ID: 32568182
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MiR-206 inhibits epithelial ovarian cancer cells growth and invasion via blocking c-Met/AKT/mTOR signaling pathway.
    Dai C; Xie Y; Zhuang X; Yuan Z
    Biomed Pharmacother; 2018 Aug; 104():763-770. PubMed ID: 29807226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-92a promotes epithelial-mesenchymal transition through activation of PTEN/PI3K/AKT signaling pathway in non-small cell lung cancer metastasis.
    Lu C; Shan Z; Hong J; Yang L
    Int J Oncol; 2017 Jul; 51(1):235-244. PubMed ID: 28534966
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-129-5p suppresses proliferation, migration and invasion of retinoblastoma cells through PI3K/AKT signaling pathway by targeting PAX6.
    Liu Y; Liang G; Wang H; Liu Z
    Pathol Res Pract; 2019 Dec; 215(12):152641. PubMed ID: 31727502
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long noncoding RNA SNHG14 accelerates cell proliferation, migration, invasion and suppresses apoptosis in colorectal cancer cells by targeting miR-944/KRAS axis through PI3K/AKT pathway.
    Pei Q; Liu GS; Li HP; Zhang Y; Xu XC; Gao H; Zhang W; Li T
    Eur Rev Med Pharmacol Sci; 2019 Nov; 23(22):9871-9881. PubMed ID: 31799655
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.